Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Larsson

Showing results (281-290 of 316) with videos related to

Pageof 32
Sort By:
Nephron|January 1, 1997
Effect of gemfibrozil on lipoprotein abnormalities in chronic renal insufficiency: a controlled study in human chronic renal diseaseO Samuelsson, P O Attman, C Knight-Gibson, et al.
Cellular and Molecular Life Sciences : CMLS|March 5, 2003
Small, novel proteins from the mistletoe Phoradendron tomentosum exhibit highly selective cytotoxicity to human breast cancer cellsS Johansson, J Gullbo, P Lindholm, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 1, 1996
Plasma levels of lipoprotein (a) do not predict progression of human chronic renal failureO Samuelsson, P O Attman, C Knight-Gibson, et al.
Bioscience Reports|November 1, 1984
Defective regulation of the cytosolic Ca2+ activity in parathyroid cells from patients with hyperparathyroidismR Larsson, C Wallfelt, H Abrahamsson, et al.
World Journal of Surgery|August 1, 1988
Monoclonal antiparathyroid antibodies revealing defect expression of a calcium receptor mechanism in hyperparathyroidismC Juhlin, G Akerström, L Klareskog, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 19, 2007
Heterogeneous activity of cytotoxic drugs in patient samples of peritoneal carcinomatosisH Mahteme, A von Heideman, B Grundmark, et al.
European Journal of Clinical Pharmacology|January 1, 1983
Prizidilol, a combined vasodilatory and beta-adrenoceptor blocking drug, in primary hypertension. A long-term efficacy, tolerance and pharmacokinetic studyB E Karlberg, R Larsson, K P Ohman, et al.
Scientific Reports|September 23, 2015
In vitro discovery of promising anti-cancer drug combinations using iterative maximisation of a therapeutic indexM Kashif, C Andersson, S Hassan, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 8, 2017
Timing and tempo of the Great Oxidation EventAshley P Gumsley, Kevin R Chamberlain, Wouter Bleeker, et al.
Anti-Cancer Drugs|November 15, 2001
Activity of CHS 828 in primary cultures of human hematological and solid tumors in vitroA Aleskog, S Bashir-Hassan, P Hovstadius, et al.
Pageof 32

Showing results (281-290 of 316) with videos related to

Sort By:
Pageof 32
Nephron|January 1, 1997
Effect of gemfibrozil on lipoprotein abnormalities in chronic renal insufficiency: a controlled study in human chronic renal diseaseO Samuelsson, P O Attman, C Knight-Gibson, et al.
Cellular and Molecular Life Sciences : CMLS|March 5, 2003
Small, novel proteins from the mistletoe Phoradendron tomentosum exhibit highly selective cytotoxicity to human breast cancer cellsS Johansson, J Gullbo, P Lindholm, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 1, 1996
Plasma levels of lipoprotein (a) do not predict progression of human chronic renal failureO Samuelsson, P O Attman, C Knight-Gibson, et al.
Bioscience Reports|November 1, 1984
Defective regulation of the cytosolic Ca2+ activity in parathyroid cells from patients with hyperparathyroidismR Larsson, C Wallfelt, H Abrahamsson, et al.
World Journal of Surgery|August 1, 1988
Monoclonal antiparathyroid antibodies revealing defect expression of a calcium receptor mechanism in hyperparathyroidismC Juhlin, G Akerström, L Klareskog, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 19, 2007
Heterogeneous activity of cytotoxic drugs in patient samples of peritoneal carcinomatosisH Mahteme, A von Heideman, B Grundmark, et al.
European Journal of Clinical Pharmacology|January 1, 1983
Prizidilol, a combined vasodilatory and beta-adrenoceptor blocking drug, in primary hypertension. A long-term efficacy, tolerance and pharmacokinetic studyB E Karlberg, R Larsson, K P Ohman, et al.
Scientific Reports|September 23, 2015
In vitro discovery of promising anti-cancer drug combinations using iterative maximisation of a therapeutic indexM Kashif, C Andersson, S Hassan, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 8, 2017
Timing and tempo of the Great Oxidation EventAshley P Gumsley, Kevin R Chamberlain, Wouter Bleeker, et al.
Anti-Cancer Drugs|November 15, 2001
Activity of CHS 828 in primary cultures of human hematological and solid tumors in vitroA Aleskog, S Bashir-Hassan, P Hovstadius, et al.
Pageof 32